Everand Logo

Welcome to Everand!

  • Discover this podcast and so much more

    Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

    NEJM Interview: Dr. Julie Gerberding on the past half-century of vaccine development and policy.

    NEJM Interview: Dr. Julie Gerberding on the past half-century of vaccine development and policy.

    FromNEJM Interviews

    Start listeningView podcast show

    NEJM Interview: Dr. Julie Gerberding on the past half-century of vaccine development and policy.

    FromNEJM Interviews

    ratings:
    Length:
    14 minutes
    Released:
    Feb 3, 2021
    Format:
    Podcast episode

    Description

    Dr. Julie Gerberding is chief patient officer and executive vice president at Merck. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. J.L. Gerberding and B.F. Haynes. Vaccine Innovations — Past and Future. N Engl J Med 2021;384:393-396.
    Released:
    Feb 3, 2021
    Format:
    Podcast episode

    Titles in the series (100)

    The New England Journal of Medicine (NEJM) Audio interview RSS feed. NEJM (http://www.nejm.org) is a weekly general medical journal that publishes new medical research findings, review articles, and editorial opinion on a wide variety of topics of importance to biomedical science and clinical practice.